000130850 001__ 130850
000130850 005__ 20240228143501.0
000130850 0247_ $$2doi$$a10.3324/haematol.2015.136929
000130850 0247_ $$2pmid$$apmid:26611471
000130850 0247_ $$2pmc$$apmc:PMC4815741
000130850 0247_ $$2ISSN$$a0390-6078
000130850 0247_ $$2ISSN$$a1592-8721
000130850 0247_ $$2altmetric$$aaltmetric:4827845
000130850 037__ $$aDKFZ-2017-05928
000130850 041__ $$aeng
000130850 082__ $$a610
000130850 1001_ $$aWeinhold, Niels$$b0
000130850 245__ $$aConcomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma.
000130850 260__ $$aPavia$$bFerrata Storti Foundation$$c2016
000130850 3367_ $$2DRIVER$$aarticle
000130850 3367_ $$2DataCite$$aOutput Types/Journal article
000130850 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1524555889_9508
000130850 3367_ $$2BibTeX$$aARTICLE
000130850 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000130850 3367_ $$00$$2EndNote$$aJournal Article
000130850 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000130850 588__ $$aDataset connected to CrossRef, PubMed,
000130850 650_7 $$2NLM Chemicals$$aAntineoplastic Agents
000130850 650_7 $$2NLM Chemicals$$aMYC protein, human
000130850 650_7 $$2NLM Chemicals$$aProto-Oncogene Proteins c-myc
000130850 7001_ $$aKirn, Desiree$$b1
000130850 7001_ $$aSeckinger, Anja$$b2
000130850 7001_ $$0P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aHielscher, Thomas$$b3$$udkfz
000130850 7001_ $$aGranzow, Martin$$b4
000130850 7001_ $$aBertsch, Uta$$b5
000130850 7001_ $$aEgerer, Gerlinde$$b6
000130850 7001_ $$aSalwender, Hans$$b7
000130850 7001_ $$aBlau, Igor W$$b8
000130850 7001_ $$aWeisel, Katja$$b9
000130850 7001_ $$0P:(DE-He78)7ccc574e713526d2a22d7acb9b2248c5$$aHillengass, Jens$$b10$$udkfz
000130850 7001_ $$0P:(DE-He78)1cb537e833afd985097ccfaddffb2ef3$$aRaab, Marc-Steffen$$b11$$udkfz
000130850 7001_ $$aHose, Dirk$$b12
000130850 7001_ $$0P:(DE-He78)a1aa959d47e3e026abe157a8adf24b96$$aGoldschmidt, Hartmut$$b13$$udkfz
000130850 7001_ $$aJauch, Anna$$b14
000130850 773__ $$0PERI:(DE-600)2805244-4$$a10.3324/haematol.2015.136929$$gVol. 101, no. 3, p. e116 - e119$$n3$$pe116 - e119$$tHaematologica$$v101$$x1592-8721$$y2016
000130850 909CO $$ooai:inrepo02.dkfz.de:130850$$pVDB
000130850 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000130850 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7ccc574e713526d2a22d7acb9b2248c5$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000130850 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1cb537e833afd985097ccfaddffb2ef3$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000130850 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a1aa959d47e3e026abe157a8adf24b96$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000130850 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000130850 9141_ $$y2016
000130850 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000130850 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000130850 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000130850 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000130850 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000130850 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000130850 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000130850 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000130850 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000130850 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000130850 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000130850 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000130850 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000130850 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x0
000130850 9201_ $$0I:(DE-He78)E010-20160331$$kE010$$lRadiologie$$x1
000130850 9201_ $$0I:(DE-He78)G170-20160331$$kG170$$lExperimentelle Therapien hämatologischer Neoplasien$$x2
000130850 9201_ $$0I:(DE-He78)G330-20160331$$kG330$$lKKE Molekulare Hämatologie/Onkologie$$x3
000130850 9201_ $$0I:(DE-He78)V964-20160331$$kV964$$lNCT-KliHD$$x4
000130850 980__ $$ajournal
000130850 980__ $$aVDB
000130850 980__ $$aI:(DE-He78)C060-20160331
000130850 980__ $$aI:(DE-He78)E010-20160331
000130850 980__ $$aI:(DE-He78)G170-20160331
000130850 980__ $$aI:(DE-He78)G330-20160331
000130850 980__ $$aI:(DE-He78)V964-20160331
000130850 980__ $$aUNRESTRICTED